# CaraVan Biologix, Inc. — Form D

CaraVan Biologix, Inc. of ANDOVER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-22. The offering totals $5.0M, of which $1.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-22
- Form: D
- Accession: 0001837437-22-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.7M
- Remaining: $3.3M
- Investors: 12
- Date of first sale: 2022-03-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438398

## Issuer

- Name: CaraVan Biologix, Inc.
- CIK: 0001837437
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6 SUNNY LANE, ANDOVER, NJ, 07821
- Phone: 908-798-0147

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Llew Keltner | Director | Andover, NJ |
| Thomas Malcolm | Director | Andover, NJ |
| MICHAEL MARTINO | Director | NEW YORK, NY |
| Jeffrey Riley | Director | Nampa, ID |
| Thomas Malcolm | Executive Officer | Andover, NJ |
| Jeffrey Riley | Executive Officer | Nampa, ID |
| David Rowe | Executive Officer | BOCA RATON, FL |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-12-28](https://search.stillhousedata.com/formd/0001837437-20-000001) | D | $550K | $390K |

## More

- [CIK 1837437 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1837437&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001837437-22-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.